Stem cell transplant for scleroderma in Turkey typically costs from AUD $78,562 to AUD $121,414. The total depends on the protocol complexity, cell source, and hospital stay duration. In Australia, this procedure averages AUD $123,556, meaning patients can save approximately 36%. Standard packages often include specialist consultations, blood work, imaging, and around 21 days of hospitalisation.
Bookimed Expert Insight: Choosing a comprehensive facility provides significant value beyond the procedure itself. Memorial Göztepe Hospital, for example, offers 300 beds and 19 operating rooms within a 2025-built facility. This scale allows for rapid diagnostic testing and immediate access to intensive care if required. Patients should prioritise centres with integrated multidisciplinary teams to manage complex systemic autoimmune conditions effectively.
| Turkey | Thailand | ||
| Stem cell transplant for scleroderma | from AUD $78,562 | from AUD $42,852 | from AUD $26,425 |
No hidden fees – just official clinic prices. Pay at the clinic for Stem cell transplant for scleroderma upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Stem cell transplant for scleroderma and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Stem cell transplant for scleroderma journey.
Dr. Cemal Firat is a professor of plastic surgery at Medical Park Antalya. He focuses on microsurgery and complex reconstructive procedures. He treats nerve injuries, cleft palates, and skin tumors. Dr. Firat works at a facility that holds international health tourism certification.
Op. Dr. Semih Özçınar is a plastic, reconstructive, and aesthetic surgeon. He earned his M.D. from Ankara University and completed his plastic surgery residency at İnönü University. He is a member of the International Society of Aesthetic Plastic Surgery (ISAPS).
His scientific work includes an oral presentation at the 2022 National Congress of the Turkish Society of Plastic, Reconstructive and Aesthetic Surgery titled "Retrospective Analysis of Regional, Free, and Local Flaps in Head and Neck Reconstruction." He also wrote a thesis on the effect of septocolumellar flap use on nasal tip projection in rhinoplasty.
He has completed training in ISAPS Live Surgery Rhinoplasty, the ISAPS World Congress 2022 in Istanbul, Bosphorus Breast Live Surgery, the 9th Rhinoplasty & Facial Aesthetics fresh cadaver course, BTS International Aesthetic in Sweden, and FABCAST meetings. His focus areas are facial aesthetics, breast surgery, body contouring, and reconstruction.
Dr. Erkan Davarci is a dermatologist at Medical Park Antalya Hospital Complex. He specializes in laser skin treatments, cosmetic dermatology, and corrective procedures. He earned his medical degree from the prestigious Ankara University. Dr. Davarci serves as a member of the Turkish Dermatology Society.
Dr. Ayse Callioglu is a dermatologist and aesthetic doctor at Medical Park Antalya Hospital Complex. She focuses on nonsurgical facial rejuvenation and dermatologic surgery. Dr. Callioglu treats various skin conditions, including dermatitis, acne, and alopecia. She works at the largest private hospital in the Mediterranean region.
Patients considering haematopoietic stem cell transplant (HSCT) for scleroderma in Turkey must evaluate suitability for autologous transplants. These procedures use the patient's own cells. Key factors include the hospital's experience with systemic sclerosis protocols. Facilities must also have intensive care units to manage transplant-related complications.
Bookimed Expert Insight: While many Turkish clinics offer general stem cell therapy from $7,200, true HSCT for scleroderma is a complex hospital-based procedure. Patients should prioritise centres like Memorial Göztepe that have multidisciplinary tumour boards and 24-hour intensive care support.
Patient Consensus: Patients suggest confirming the exact conditioning regimen. They also advise having a clear plan for managing infection risks during recovery. Most recommend budgeting for extra hospital days and arranging local rheumatology follow-up before leaving Australia.